Aminex Clinical Trials and Collaborations

Aminex Studies

• AMXT1501-101A – Oral AMXT1501dicaprate in combination with oral DFMO – Phase 1, First In Human
• AMXT1501-102 – Oral AMXT1501 dicaprate in combination with IV DVMO – Phase 1b
• AMXT1501 – Phase 2 study forthcoming

Aminex Collaborations

• Milton S. Hershey Medical Center (Pennsylvania State University): Difluoromethylornithine (DFMO) and AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas
• Mayo Clinic: Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma